*University Department of Otolaryngology, Manchester Royal Infirmary; †Department of Neurosurgery, Salford Royal Hospital; ‡Manchester Auditory Implant Centre, Manchester Royal Infirmary, Manchester, U.K.; and §Department of Medical Genetics, St Mary's Hospital, Manchester, UK.
Otol Neurotol. 2014 Jan;35(1):43-51. doi: 10.1097/MAO.0000000000000185.
To investigate the outcomes from ipsilateral simultaneous or sequential cochlear implantation in patients with neurofibromatosis type 2 (NF2) after vestibular schwannoma removal with cochlear nerve preservation.
Retrospective case series.
Single tertiary referral NF2 center.
Six patients with NF2.
Removal of vestibular schwannoma (VS) with preservation of the cochlear nerve and cochlear implantation. Four patients had their surgery via a translabyrinthine approach. Two patients had a retrosigmoid approach. A cochlear implant was inserted at the same time as tumor removal in 4 cases and sequentially in 2 cases.
Surgical and audiometric outcomes using Bamford-Kowal-Bench (BKB) and City of New York University (CUNY) sentence scores.
The average age at implantation was 24 years (range, 15-36 yr). Follow-up ranged from 5 to 93 months, with an average of 38 months. All patients had useful hearing in the contralateral ear before surgery. One patient gained no benefit from cochlear implantation and proceeded to have an auditory brainstem implant. Of those that had functional cochlear nerves, the average BKB score in quiet was 64%, BKB score in noise was 42%, and CUNY score with lipreading was 97%. Results varied within the group, but all patients gained significant benefit and continue to use their CI at least intermittantly.
The present series demonstrates that in selected cases, cochlear implantation can be successful after a translabyrinthine approach for VS removal and for restoring hearing after failed retrosigmoid hearing preservation surgery. All patients found the cochlear implant offered useful hearing even in the presence of contralateral hearing.
研究在保留耳蜗神经的情况下,对神经纤维瘤病 2 型(NF2)患者行前庭神经鞘瘤切除术后,行同侧同期或序贯耳蜗植入的效果。
回顾性病例系列研究。
单一的三级转诊 NF2 中心。
6 例 NF2 患者。
切除前庭神经鞘瘤(VS),保留耳蜗神经,并进行耳蜗植入。4 例患者经迷路入路手术,2 例患者经乙状窦后入路手术。4 例患者在肿瘤切除的同时植入耳蜗,2 例患者序贯植入。
使用 Bamford-Kowal-Bench(BKB)和纽约大学(CUNY)句子评分评估手术和听力结果。
植入时的平均年龄为 24 岁(15-36 岁)。随访时间为 5-93 个月,平均 38 个月。所有患者在手术前对侧耳均有有用听力。1 例患者植入耳蜗后无获益,继而进行了听觉脑干植入。在有功能的耳蜗神经的患者中,安静时的平均 BKB 评分为 64%,噪声下的 BKB 评分为 42%,唇读时的 CUNY 评分为 97%。组内结果存在差异,但所有患者均获得显著获益,且至少间歇性地继续使用他们的人工耳蜗。
本系列研究表明,在选择合适的病例中,经迷路入路切除 VS 并在乙状窦后听力保护手术失败后行耳蜗植入,可成功恢复听力。所有患者发现人工耳蜗提供了有用的听力,即使存在对侧听力。